CHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook
Chemed Corporation reported better-than-expected Q2 CY2026 results, driven by strong patient volume growth and improved admission trends at VITAS. While VITAS growth and disciplined cost management are positives, Roto-Rooter faces challenges with increased marketing spend due to a higher reliance on paid leads. The …